Our world-class experts. Your child’s care team.
Exceptional science. Innovative cures.
Science & medicine news
-
Researchers go deep to understand treatment response
St. Jude scientists analyzed tumor samples from a 10-year clinical trial that studied medulloblastoma.
-
Structure of enzyme that causes Parkinson’s promises pathways to new drugs
Enzyme LRRK2 is a biological switch whose mutation generates abnormal proteins in Parkinson’s patients.
-
Erica Sirrine named director of Social Work at St. Jude Children's Research Hospital
Grief and bereavement expert with years of building social work programs in academia will direct a growing program at St. Jude.
-
Collaboration controls killers
Scientists at St. Jude looked at sequences of DNA to determine how they can destroy cancer cells that resist treatment.
-
Genetic base editing shows promise for treatment of sickle cell disease
St. Jude Children's Research Hospital scientists have helped advance a new therapy for sickle cell disease.
-
Gene therapy appears more cost effective than current treatments for severe hemophilia B
St. Jude Children’s Research Hospital provides the first gene therapy manufacturing and distribution cost report for hemophilia B.